Lesleishmaniosesvues au travers du réseau international des Instituts Pasteur
Open Access
- 20 December 2013
- journal article
- abstracts
- Published by EDP Sciences in médecine/sciences
- Vol. 29 (12) , 1151-1160
Abstract
Protozoan parasites of the genus Leishmania generate severe human diseases termed leishmaniases. Due to their frequency and the severity of certain clinical forms, these diseases represent a major public health problem and limit the economic growth in various developing countries. The presence of Pasteur Institutes in countries with endemic leishmaniasis has provided important incentives to develop a strong public health agenda in the Pasteur scientific community with respect to this important disease. A concerted effort is now coordinated through the recently created LeishRIIP platform (www.leishriip.org), which aims to identify synergies and complementary expertise between the eleven members of the international network of Pasteur Institutes working on various aspects of the disease including epidemiology, diagnosis, chemotherapy and vaccination.Keywords
This publication has 58 references indexed in Scilit:
- High Content Analysis of Primary Macrophages Hosting Proliferating Leishmania Amastigotes: Application to Anti-leishmanial Drug DiscoveryPLOS Neglected Tropical Diseases, 2013
- A Global Comparative Evaluation of Commercial Immunochromatographic Rapid Diagnostic Tests for Visceral LeishmaniasisClinical Infectious Diseases, 2012
- Identification and Diagnostic Utility of Leishmania infantum Proteins Found in Urine Samples from Patients with Visceral LeishmaniasisClinical and Vaccine Immunology, 2012
- Therapeutic Vaccination With Recombinant Adenovirus Reduces Splenic Parasite Burden in Experimental Visceral LeishmaniasisThe Journal of Infectious Diseases, 2012
- The development and clinical evaluation of second-generation leishmaniasis vaccinesVaccine, 2012
- Phase 4 Pharmacovigilance Trial of Paromomycin Injection for the Treatment of Visceral Leishmaniasis in IndiaJournal of Tropical Medicine, 2011
- Diagnosis of Mediterranean Visceral Leishmaniasis by Detection of Leishmania Antibodies and Leishmania DNA in Oral Fluid Samples Collected Using an Oracol DeviceJournal of Clinical Microbiology, 2011
- Early Curative Applications of the Aminoglycoside WR279396 on an ExperimentalLeishmania major-Loaded Cutaneous Site Do Not Impair the Acquisition of ImmunityAntimicrobial Agents and Chemotherapy, 2010
- Leishmania majorMPK7 Protein Kinase Activity Inhibits Intracellular Growth of the Pathogenic Amastigote StageEukaryotic Cell, 2010
- Paromomycin: Uptake and resistance in Leishmania donovaniMolecular and Biochemical Parasitology, 2009